1. HIF1A Signaling is a Central Pathobiologic Mediator of MDS. (April 2017) Authors: Hayashi, Y.; Zhang, Y.; Yan, X.; Sashida, G.; Chetal, K.; Olsson, A.; Harada, H.; Shih, L.Y.; Tse, W.; Bridges, J.; Zheng, Y.; Witte, D.; Caligiuri, M.; Qu, C.K.; Wang, Q.F.; Salomonis, N.; Grimes, H.L.; Nimer, S.; Xiao, Z.; Huang, G. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 70 IDENTIFICATION AND TARGETING HIF-1A PATHWAY IN MDS DEVELOPMENT AND MAINTENANCE. (April 2015) Authors: Hayashi, Y.; Zhang, Y.; Yan, X.; Kuangmin, C.; Sashida, G.; Zefeng, X.; Lingyun, W.; Harada, H.; Shih, L.Y.; Tsa, W.; Witte, D.; Caligiuri, M.; Wang, Q.F.; Xiao, Z.; Huang, G. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗